FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,052 | -31.7% | 19,364 | +53.3% | 0.00% | – |
| Q2 2023 | $60,114 | -45.6% | 12,629 | +15.3% | 0.00% | – |
| Q4 2022 | $110,480 | -99.1% | 10,949 | -97.9% | 0.00% | -100.0% |
| Q3 2022 | $11,650,000 | -8.7% | 519,891 | +0.9% | 0.02% | -4.2% |
| Q2 2022 | $12,763,000 | -34.6% | 515,032 | +2.3% | 0.02% | -17.2% |
| Q1 2022 | $19,517,000 | +25.2% | 503,397 | +88.9% | 0.03% | +52.6% |
| Q4 2021 | $15,591,000 | – | 266,466 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |